Correlation Between Nascent Biotech and BiOasis Technologies

Can any of the company-specific risk be diversified away by investing in both Nascent Biotech and BiOasis Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nascent Biotech and BiOasis Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nascent Biotech and biOasis Technologies, you can compare the effects of market volatilities on Nascent Biotech and BiOasis Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nascent Biotech with a short position of BiOasis Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nascent Biotech and BiOasis Technologies.

Diversification Opportunities for Nascent Biotech and BiOasis Technologies

-0.31

Correlation Coefficient

Nascent Biotech  BiOasis Technologies

Very good diversification

The 3 months correlation between Nascent and BiOasis is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Nascent Biotech and biOasis Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on biOasis Technologies and Nascent Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nascent Biotech are associated (or correlated) with BiOasis Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of biOasis Technologies has no effect on the direction of Nascent Biotech i.e., Nascent Biotech and BiOasis Technologies go up and down completely randomly.

Pair Corralation between Nascent Biotech and BiOasis Technologies

Given the investment horizon of 90 days Nascent Biotech is expected to generate 2.14 times more return on investment than BiOasis Technologies. However, Nascent Biotech is 2.14 times more volatile than biOasis Technologies. It trades about 0.15 of its potential returns per unit of risk. biOasis Technologies is currently generating about 0.14 per unit of risk. If you would invest  5.05  in Nascent Biotech on December 29, 2024 and sell it today you would lose (4.40) from holding Nascent Biotech or give up 87.13% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	96.88%
Values	Daily Returns

Nascent Biotech  vs.  biOasis Technologies

Nascent Biotech

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Nascent Biotech are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Nascent Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

biOasis Technologies

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in biOasis Technologies are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BiOasis Technologies reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nascent Biotech and BiOasis Technologies

The main advantage of trading using opposite Nascent Biotech and BiOasis Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nascent Biotech position performs unexpectedly, BiOasis Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BiOasis Technologies will offset losses from the drop in BiOasis Technologies' long position.

The idea behind Nascent Biotech and biOasis Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.